Previous Article | Next Article 
Molecular and Cellular Biology, June 2005, p. 5052-5060, Vol. 25, No. 12
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.12.5052-5060.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
The HRPT2 Tumor Suppressor Gene Product Parafibromin Associates with Human PAF1 and RNA Polymerase II
Armelle Yart,1
Matthias Gstaiger,1
Christiane Wirbelauer,2
Maria Pecnik,1
Dimitrios Anastasiou,1
Daniel Hess,2 and
Wilhelm Krek1*
Institute of Cell Biology, ETH Hönggerberg, CH-8093 Zurich, Switzerland,1
Friedrich Miescher Institute, Maulbeerstrasse 66, CH-4058 Basel, Switzerland2
Received 17 November 2004/
Returned for modification 21 December 2004/
Accepted 8 March 2005
Inactivation of the HRPT2 tumor suppressor gene is associated with the pathogenesis of the hereditary hyperparathyroidism-jaw tumor syndrome and malignancy in sporadic parathyroid tumors. The cellular function of the HPRT2 gene product, parafibromin, has not been defined yet. Here we show that parafibromin physically interacts with human orthologs of yeast Paf1 complex components, including PAF1, LEO1, and CTR9, that are involved in transcription elongation and 3' end processing. It also associates with modified forms of the large subunit of RNA polymerase II, in particular those phosphorylated on serine 5 or 2 within the carboxy-terminal domain, that are important for the coordinate recruitment of transcription elongation and RNA processing machineries during the transcription cycle. These interactions depend on a C-terminal domain of parafibromin, which is deleted in ca. 80% of clinically relevant mutations. Finally, RNAi-induced downregulation of parafibromin promotes entry into S phase, implying a role for parafibromin as an inhibitor of cell cycle progression. Taken together, these findings link the tumor suppressor parafibromin to the transcription elongation and RNA processing pathway as a PAF1 complex- and RNA polymerase II-bound protein. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary parathyroid cancer.
* Corresponding author. Mailing address: Institute of Cell Biology, ETH Hönggerberg, CH-8093 Zurich, Switzerland. Phone: 41-44-633-3447. Fax: 41-44-633-1357. E-mail:
wilhelm.krek{at}cell.biol.ethz.ch.
Molecular and Cellular Biology, June 2005, p. 5052-5060, Vol. 25, No. 12
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.12.5052-5060.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yang, Y.-J., Han, J.-W., Youn, H.-D., Cho, E.-J.
(2009). The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res
0: gkp991v1-gkp991
[Abstract]
[Full Text]
-
Hahn, M. A, McDonnell, J., Marsh, D. J
(2009). The effect of disease-associated HRPT2 mutations on splicing. J Endocrinol
201: 387-396
[Abstract]
[Full Text]
-
Rozenblatt-Rosen, O., Nagaike, T., Francis, J. M., Kaneko, S., Glatt, K. A., Hughes, C. M., LaFramboise, T., Manley, J. L., Meyerson, M.
(2009). The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. Proc. Natl. Acad. Sci. USA
106: 755-760
[Abstract]
[Full Text]
-
Masi, G., Barzon, L., Iacobone, M., Viel, G., Porzionato, A., Macchi, V., De Caro, R., Favia, G., Palu, G.
(2008). Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer
15: 1115-1126
[Abstract]
[Full Text]
-
Lin, L., Zhang, J.-H., Panicker, L. M., Simonds, W. F.
(2008). The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc. Natl. Acad. Sci. USA
105: 17420-17425
[Abstract]
[Full Text]
-
Nordick, K., Hoffman, M. G., Betz, J. L., Jaehning, J. A.
(2008). Direct Interactions between the Paf1 Complex and a Cleavage and Polyadenylation Factor Are Revealed by Dissociation of Paf1 from RNA Polymerase II. Eukaryot Cell
7: 1158-1167
[Abstract]
[Full Text]
-
Mozdy, A. D., Podell, E. R., Cech, T. R.
(2008). Multiple Yeast Genes, Including Paf1 Complex Genes, Affect Telomere Length via Telomerase RNA Abundance. Mol. Cell. Biol.
28: 4152-4161
[Abstract]
[Full Text]
-
Sustmann, C., Flach, H., Ebert, H., Eastman, Q., Grosschedl, R.
(2008). Cell-Type-Specific Function of BCL9 Involves a Transcriptional Activation Domain That Synergizes with {beta}-Catenin. Mol. Cell. Biol.
28: 3526-3537
[Abstract]
[Full Text]
-
Wang, P., Bowl, M. R., Bender, S., Peng, J., Farber, L., Chen, J., Ali, A., Zhang, Z., Alberts, A. S., Thakker, R. V., Shilatifard, A., Williams, B. O., Teh, B. T.
(2008). Parafibromin, a Component of the Human PAF Complex, Regulates Growth Factors and Is Required for Embryonic Development and Survival in Adult Mice. Mol. Cell. Biol.
28: 2930-2940
[Abstract]
[Full Text]
-
Selvarajan, S, Sii, L-H, Lee, A, Yip, G, Bay, B-H, Tan, M-H, Teh, B-T, Tan, P-H
(2008). Parafibromin expression in breast cancer: a novel marker for prognostication?. J. Clin. Pathol.
61: 64-67
[Abstract]
[Full Text]
-
Youn, M.-Y., Yoo, H.-S., Kim, M.-J., Hwang, S.-Y., Choi, Y., Desiderio, S. V., Yoo, J.-Y.
(2007). hCTR9, a Component of Paf1 Complex, Participates in the Transcription of Interleukin 6-responsive Genes through Regulation of STAT3-DNA Interactions. J. Biol. Chem.
282: 34727-34734
[Abstract]
[Full Text]
-
Warner, M. H., Roinick, K. L., Arndt, K. M.
(2007). Rtf1 Is a Multifunctional Component of the Paf1 Complex That Regulates Gene Expression by Directing Cotranscriptional Histone Modification. Mol. Cell. Biol.
27: 6103-6115
[Abstract]
[Full Text]
-
Juhlin, C C, Villablanca, A, Sandelin, K, Haglund, F, Nordenstrom, J, Forsberg, L, Branstrom, R, Obara, T, Arnold, A, Larsson, C, Hoog, A
(2007). Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer
14: 501-512
[Abstract]
[Full Text]
-
Cetani, F., Ambrogini, E., Viacava, P., Pardi, E., Fanelli, G., Naccarato, A. G., Borsari, S., Lemmi, M., Berti, P., Miccoli, P., Pinchera, A., Marcocci, C.
(2007). Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?. Eur J Endocrinol
156: 547-554
[Abstract]
[Full Text]
-
Lin, L., Czapiga, M., Nini, L., Zhang, J.-H., Simonds, W. F.
(2007). Nuclear Localization of the Parafibromin Tumor Suppressor Protein Implicated in the Hyperparathyroidism-Jaw Tumor Syndrome Enhances Its Proapoptotic Function. Mol Cancer Res
5: 183-193
[Abstract]
[Full Text]
-
Vakoc, C. R., Sachdeva, M. M., Wang, H., Blobel, G. A.
(2006). Profile of Histone Lysine Methylation across Transcribed Mammalian Chromatin. Mol. Cell. Biol.
26: 9185-9195
[Abstract]
[Full Text]
-
Scott, R H, Stiller, C A, Walker, L, Rahman, N
(2006). Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J. Med. Genet.
43: 705-715
[Abstract]
[Full Text]
-
Guarnieri, V., Scillitani, A., Muscarella, L. A., Battista, C., Bonfitto, N., Bisceglia, M., Minisola, S., Mascia, M. L., D'Agruma, L., Cole, D. E. C.
(2006). Diagnosis of Parathyroid Tumors in Familial Isolated Hyperparathyroidism with HRPT2 Mutation: Implications for Cancer Surveillance. J. Clin. Endocrinol. Metab.
91: 2827-2832
[Abstract]
[Full Text]
-
Juhlin, C, Larsson, C, Yakoleva, T, Leibiger, I, Leibiger, B, Alimov, A, Weber, G, Hoog, A, Villablanca, A
(2006). Loss of parafibromin expression in a subset of parathyroid adenomas.. Endocr Relat Cancer
13: 509-523
[Abstract]
[Full Text]
-
Parusel, C. T., Kritikou, E. A., Hengartner, M. O., Krek, W., Gotta, M.
(2006). URI-1 is required for DNA stability in C. elegans. Development
133: 621-629
[Abstract]
[Full Text]
-
Adelman, K., Wei, W., Ardehali, M. B., Werner, J., Zhu, B., Reinberg, D., Lis, J. T.
(2006). Drosophila Paf1 Modulates Chromatin Structure at Actively Transcribed Genes. Mol. Cell. Biol.
26: 250-260
[Abstract]
[Full Text]
-
Rubin, M. R., Silverberg, S. J.
(2005). HRPT2 in Parathyroid Cancer: A Piece of the Puzzle. J. Clin. Endocrinol. Metab.
90: 5505-5507
[Full Text]